Monday, June 9, 2008

Marijuana Doesn't Always Led To The Munchies


A new weight loss treatment SR141716, (also known as Rimonabant, Acomplia, Riobant, Slimona, Rimoslim, and Zimulti) is a cannabis based anti-obesity drug developed by the French pharma firm Sanofi-Aventi. Its main avenue of effect is reduction in appetite.

I have always been under the impression that smoking marijuana led to an increase in appetite or 'the munchies' as it's known in popular culture. That over whelming urge to eat following smoking pot has been well documented in movies and articles over the years. However, marijuana may not always led to the 'munchies, weight Loss and appetite regulation is another proposed medical use of marijuana.

The legal or licensed use of cannabis derivatives in medicine is a controversial one and frequently debated on a national level. Though marijuana is primarily known as an illegal recreational drug, cannabis has been used for medicinal purposes for hundreds of years. Weight Loss is just one of the proposed medical uses of cannabinoids.

In fact, there is a new treatment already approved and available, SR141716, (also known as Rimonabant, Acomplia, Riobant, Slimona, Rimoslim, and Zimulti), which does contain cannabinoids.

The cannabis plant has 70 different cannabinoids in it, and each has a different effect on the body. Some can stimulate your appetite, and some, as is the case with SR141716, can suppress your appetite.

In the UK, it has been available since the end of July 2006. As of 2007, the drug was available in 38 countries. The approval is in combination with diet and exercise for the treatment of obese patients (BMI greater than or equal to 30), or overweight patients (BMI greater than 27) with associated risk factors, such as type 2 diabetes or dyslipidaemia.

The EU's approval was not a blanket approval, nor did it approve SR141716 for non-obesity related problems such as smoking cessation, although SR141746 may also be found to be effective in assisting some smokers to quit smoking. Sanofi-Aventis is currently conducting studies to determine the possible value of SR141716 in smoking-cessation therapy.

Research into further use of the compounds of the cannabis plant is ongoing and scientists studying marijuana's potential medical uses have found that it may help treat a variety of conditions.

Well documented potential medical benefits of marijuana include pain relief , the treatment of nausea, and multiple sclerosis.

You can buy Zimulti here

.
mook's weblog

No comments: